Research focuses on antiviral therapy evaluation and resistance dynamics, linking clinical pharmacokinetics with real‑world outcomes. Work integrates pharmacoepidemiology, pharmacogenetics, and vaccine immunology to inform prevention and treatment strategies for infectious diseases.